Diabetic Patients at a Higher Risk of Actos Bladder Cancer
On 16th June 2012, the FDA issued a warning about the increased cases of bladder cancer associated with the drug Actos. The warning of Actos bladder cancer came in the wake of a 5 year analysis review of the product carried out by the manufacturer Takeda Pharmaceuticals. These results indicate that while there is an […]